Clinical Trials: Phase II Trial of Sorafenib and Dacarbazine in Soft Tissue Sarcoma
Sponsor and Collaborators
Memorial Sloan-Kettering Cancer Center
Bayer
Contact
David D'Adamo, MD, PhD
212-639-7573
Mary Louise Keohan, MD
212-639-2809
Principal Investigator
David D'Adamo, MD, PhD, Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier
NCT00837148
